Jump Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.92M | Buy |
13,292
+12,084
| +1,000% | +$5.38M | 0.07% | 357 |
|
|
2025
Q1 | $586K | Sell |
1,208
-1,833
| -60% | -$889K | 0.01% | 1005 |
|
|
2024
Q4 | $1.22M | Buy |
3,041
+72
| +2% | +$29K | 0.03% | 671 |
|
|
2024
Q3 | $1.38M | Sell |
2,969
-12,037
| -80% | -$5.6M | 0.03% | 660 |
|
|
2024
Q2 | $7.03M | Buy |
15,006
+6,401
| +74% | +$3M | 0.14% | 150 |
|
|
2024
Q1 | $3.6M | Sell |
8,605
-22,023
| -72% | -$9.21M | 0.1% | 221 |
|
|
2023
Q4 | $12.5M | Buy |
30,628
+20,163
| +193% | +$8.2M | 0.4% | 27 |
|
|
2023
Q3 | $3.64M | Buy |
10,465
+3,180
| +44% | +$1.11M | 0.13% | 181 |
|
|
2023
Q2 | $2.56M | Buy |
+7,285
| New | +$2.56M | 0.09% | 296 |
|
|
2022
Q4 | – | Sell |
-1,917
| Closed | -$555K | – | 2060 |
|
|
2022
Q3 | $555K | Buy |
+1,917
| New | +$555K | 0.02% | 852 |
|
|
2022
Q2 | – | Sell |
-1,045
| Closed | -$273K | – | 2052 |
|
|
2022
Q1 | $273K | Sell |
1,045
-17,122
| -94% | -$4.47M | 0.01% | 1120 |
|
|
2021
Q4 | $3.99M | Buy |
+18,167
| New | +$3.99M | 0.25% | 34 |
|
|
2021
Q2 | – | Sell |
-1,732
| Closed | -$372K | – | 1411 |
|
|
2021
Q1 | $372K | Buy |
+1,732
| New | +$372K | 0.03% | 520 |
|
|
2020
Q4 | – | Sell |
-1,259
| Closed | -$343K | – | 1193 |
|
|
2020
Q3 | $343K | Buy |
+1,259
| New | +$343K | 0.07% | 451 |
|